| Literature DB >> 32300622 |
Shuyu Han1, Yan Hu1, Zheng Zhu1, Bei Wu2.
Abstract
Globally, persons living with HIV (PLWH) are vulnerable to depressive and anxious symptoms [1]. Cognitive behavioural therapy (CBT) is one of the first-line mental health treatment strategies for PLWH [2-3]. However, structured and systematic cognitive behavioural intervention (CBI) is rare for PLWH in China. This data article presents the raw data of a parallel two-arm randomized controlled trial investigating the preliminary effects of CBI on depression, anxiety, medication adherence, quality of life, and CD4 lymphocyte counts for PLWH in China. Twenty PLWH who aged ≥18, were undergoing antiretroviral therapy (ART), and scored the Patient Health Questionnaire-4 (PHQ-4) ≥2 were recruited face-to-face and randomly assigned to groups based on computerized random number generation. Intervention participants received a tailored group-based 10-week-long CBI. Control participants only took laboratory tests and received free ART medication. The data includes demographic variables, exposure variables and outcomes. The outcomes were repeated-measured at baseline (T0), after the intervention (T1), and after 6 months of follow-up (T2). We assessed depression and anxiety via the Hospital Anxiety and Depression Scale (HADS), quality of life via the WHOQOL-HIV BREF, medication adherence via self-report adherence, the visual analog scale (VAS) and the medication possession ratio (MPR). CD4 lymphocyte counts were available on participants' medical records. The main manuscript of this dataset is "cognitive behavioral intervention for persons living with HIV in China: a randomized pilot trial" (Han et al., submitted for publication) [4].Entities:
Keywords: AIDS; Anxiety; Cognitive behavioural therapy; Depression; HIV; Medication adherence; Randomized controlled trial
Year: 2020 PMID: 32300622 PMCID: PMC7153287 DOI: 10.1016/j.dib.2020.105459
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Demographic variables of the study.
| ID | Age | Gender | Household register | Race | Education | Religion | Employment status | Marital status |
|---|---|---|---|---|---|---|---|---|
| 1 | 44 | 1 | 1 | 1 | 6 | 2 | 1 | 2 |
| 2 | 26 | 1 | 2 | 1 | 4 | 1 | 1 | 2 |
| 3 | 36 | 1 | 1 | 1 | 5 | 2 | 1 | 2 |
| 4 | 48 | 1 | 2 | 1 | 5 | 1 | 4 | 1 |
| 5 | 35 | 1 | 2 | 1 | 6 | 2 | 1 | 2 |
| 6 | 32 | 1 | 1 | 1 | 5 | 1 | 1 | 2 |
| 7 | 42 | 1 | 2 | 2 | 6 | 2 | 1 | 2 |
| 8 | 43 | 1 | 2 | 1 | 2 | 1 | 1 | 2 |
| 9 | 55 | 1 | 1 | 1 | 6 | 1 | 1 | 1 |
| 10 | 29 | 1 | 2 | 1 | 5 | 2 | 1 | 1 |
| 11 | 27 | 1 | 1 | 1 | 5 | 1 | 1 | 2 |
| 12 | 38 | 1 | 1 | 1 | 5 | 1 | 1 | 2 |
| 13 | 30 | 1 | 1 | 1 | 6 | 1 | 1 | 2 |
| 14 | 35 | 1 | 2 | 1 | 5 | 1 | 1 | 2 |
| 15 | 37 | 1 | 2 | 1 | 5 | 2 | 1 | 2 |
| 16 | 37 | 1 | 2 | 1 | 4 | 1 | 1 | 1 |
| 17 | 24 | 1 | 2 | 1 | 5 | 2 | 1 | 2 |
| 18 | 25 | 1 | 2 | 1 | 5 | 2 | 2 | 2 |
| 19 | 35 | 1 | 2 | 1 | 5 | 1 | 1 | 2 |
| 20 | 45 | 1 | 1 | 1 | 4 | 2 | 1 | 2 |
Note: Patients 1–10:intervention group; Patients 11–20:control group.
Gender: 1 = Male; 2 = Female.
Household register: 1 = Shanghai; 2 = Non-Shanghai.
Race: 1 = Han; 2 = Minority.
Education: 1 = Primary school or less; 2 = Junior high school; 3 = Senior high school; 4 = College; 5 = University; 6 = Master or higher.
Religion: 1 = No; 2 = Yes.
Employment status: 1 = Employed; 2 = Unemployed; 3 = Sick leave; 4 = Retired.
Marital status: 1 = Married; 2 = Single.
Exposure variables (Attendance rates).
| ID | Sessions | Attendance | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ||
| 1 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | 10 |
| 2 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | 9 |
| 3 | √ | √ | √ | √ | √ | √ | √ | 7 | |||
| 4 | √ | √ | √ | √ | √ | √ | √ | 7 | |||
| 5 | √ | √ | √ | √ | √ | √ | 6 | ||||
| 6 | √ | √ | √ | √ | √ | √ | √ | √ | √ | 9 | |
| 7 | √ | 1 | |||||||||
| 8 | √ | 1 | |||||||||
| 9 | √ | √ | √ | √ | 4 | ||||||
| 10 | √ | √ | √ | √ | √ | √ | 6 | ||||
PHQ-4 and HIV-related variables.
| ID | PHQ-4 | Transmission mode | CD4 lymphocyte count(/µL) | HIV-RNA | Years of HIV diagnosis | Years of receiving ART |
|---|---|---|---|---|---|---|
| 1 | 4 | 1 | 376 | 0 | 1 | 1 |
| 2 | 3 | 1 | 370 | 0 | 1 | 1 |
| 3 | 6 | 1 | 266 | 0 | 1 | 1 |
| 4 | 4 | 2 | 197 | 0 | 2 | 2 |
| 5 | 5 | 1 | 253 | 0 | 6 | 6 |
| 6 | 5 | 1 | 356 | 0 | 6 | 6 |
| 7 | 10 | 1 | 768 | 0 | 8 | 7 |
| 8 | 4 | 1 | 443 | 0 | 8 | 7 |
| 9 | 5 | 1 | 409 | 0 | 9 | 8 |
| 10 | 6 | 3 | 372 | 0 | 4 | 4 |
| 11 | 2 | 3 | 433 | 0 | 1 | 1 |
| 12 | 4 | 1 | 509 | 0 | 7 | 2 |
| 13 | 4 | 1 | 339 | 0 | 2 | 2 |
| 14 | 5 | 1 | 549 | 0 | 3 | 3 |
| 15 | 2 | 1 | 295 | 0 | 3 | 3 |
| 16 | 10 | 1 | 436 | 0 | 4 | 4 |
| 17 | 3 | 1 | 539 | 0 | 4 | 4 |
| 18 | 5 | 1 | 481 | 0 | 4 | 4 |
| 19 | 9 | 1 | 265 | 0 | 5 | 5 |
| 20 | 4 | 4 | 449 | 0 | 5 | 5 |
Note: Patients 1–10: intervention group; Patients 11–20: control group.
Transmission mode: 1 = Homosexual behavior; 2 = Heterosexual behavior; 3 = Unknown; 4 = Other.
HIV-RNA: 0 = Undetectable; 1 = Detectable.
Years of HIV diagnosis: how many years has the participants been diagnosed with HIV infection?
Years of receiving ART: how many years has the participants been taking ART?
Outcomes at baseline (T0).
| ID | Anxiety | Depression | Negative emotion | Physical domain | Psychological domain | Independence domain | Social domain | Environment domain | Spirituality domain | Quality of life | VAS | Self-report adherence | MPR | MPR (binary) | CD4(/µL) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 13 | 10 | 23 | 18 | 21 | 19 | 15 | 38 | 17 | 136 | 100 | 2 | 1.03 | 2 | 376 |
| 2 | 11 | 11 | 22 | 16 | 19 | 15 | 17 | 30 | 14 | 119 | 100 | 2 | 1.06 | 2 | 370 |
| 3 | 17 | 20 | 37 | 11 | 8 | 12 | 12 | 21 | 13 | 83 | 100 | 2 | 0.99 | 2 | 266 |
| 4 | 15 | 11 | 26 | 17 | 21 | 16 | 18 | 36 | 20 | 137 | 90 | 2 | 0.99 | 2 | 197 |
| 5 | 14 | 10 | 24 | 11 | 17 | 11 | 14 | 28 | 18 | 104 | 95 | 1 | 1.22 | 2 | 253 |
| 6 | 13 | 15 | 28 | 14 | 14 | 12 | 13 | 23 | 16 | 97 | 98 | 1 | 1.01 | 2 | 356 |
| 7 | 22 | 14 | 36 | 12 | 16 | 17 | 14 | 21 | 12 | 98 | 95 | 1 | 1.17 | 2 | 768 |
| 8 | 15 | 15 | 30 | 14 | 14 | 14 | 12 | 28 | 14 | 102 | 85 | 1 | 1.13 | 2 | 443 |
| 9 | 17 | 12 | 29 | 16 | 19 | 16 | 14 | 31 | 14 | 118 | 100 | 1 | 1.01 | 2 | 409 |
| 10 | 13 | 11 | 24 | 14 | 15 | 15 | 14 | 26 | 15 | 105 | 98 | 1 | 1.00 | 2 | 372 |
| 11 | 10 | 13 | 23 | 18 | 17 | 16 | 17 | 34 | 18 | 128 | 100 | 2 | 1.00 | 2 | 433 |
| 12 | 14 | 11 | 25 | 14 | 16 | 15 | 15 | 34 | 17 | 119 | 100 | 2 | 0.99 | 2 | 509 |
| 13 | 15 | 11 | 26 | 15 | 19 | 17 | 18 | 30 | 16 | 124 | 90 | 1 | 0.91 | 1 | 339 |
| 14 | 15 | 10 | 25 | 17 | 18 | 13 | 12 | 31 | 17 | 116 | 100 | 2 | 1.38 | 2 | 549 |
| 15 | 13 | 10 | 23 | 15 | 17 | 14 | 16 | 31 | 18 | 118 | 95 | 2 | 1.14 | 2 | 295 |
| 16 | 23 | 16 | 39 | 12 | 12 | 11 | 9 | 16 | 12 | 78 | 100 | 2 | 0.92 | 1 | 436 |
| 17 | 14 | 11 | 25 | 15 | 15 | 12 | 11 | 26 | 19 | 105 | 98 | 1 | 1.17 | 2 | 539 |
| 18 | 13 | 16 | 29 | 13 | 15 | 14 | 12 | 29 | 17 | 105 | 80 | 1 | 1.00 | 2 | 481 |
| 19 | 17 | 14 | 31 | 13 | 14 | 11 | 13 | 25 | 13 | 95 | 95 | 1 | 0.97 | 2 | 265 |
| 20 | 13 | 11 | 24 | 20 | 16 | 14 | 13 | 31 | 20 | 123 | 95 | 1 | 0.92 | 1 | 449 |
Note: Patients 1–10: intervention group; Patients 11–20: control group.
Anxiety: range from 7 to 28.
Depression: range from 7 to 28.
Negative emotion = Anxiety+Depression, range from 14 to 56.
Physical domain: range from 4 to 20.
Psychological domain: range 5 to 25.
Independence domain: range from 4 to 20.
Social domain: range from 4 to 20.
Environment domain: range from 8 to 40.
Spirituality domain: range from 4 to 20.
Quality of life = Physical domain+Psychological domain+Independence domain+Social domain+Environment domain+Spirituality domain+2 general items, range from 31 to 155.
VAS: visual analogue scale, range from 0 to 100.
Self-report adherence:1 = modest,2 = good.
MPR: medication possession ratio = time interval between two prescriptions/90.
MPR(binary):1 = modest(MPR<0.95),2 = good(MPR≥0.95).
Outcomes at the 6-month follow-up (T2).
| ID | Anxiety | Depression | Negative emotion | Physical domain | Psychological domain | Independence domain | Social domain | Environment domain | Spirituality domain | Quality of life | VAS | Self-report adherence | MPR | MPR (binary) | CD4 (/µL) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 15 | 14 | 29 | 18 | 19 | 18 | 14 | 34 | 17 | 128 | 100 | 2 | 0.93 | 1 | 532 |
| 2 | 15 | 15 | 30 | 14 | 15 | 12 | 11 | 25 | 12 | 94 | 100 | 2 | 1.29 | 2 | 498 |
| 3 | 16 | 20 | 36 | 10 | 11 | 12 | 11 | 22 | 14 | 85 | 100 | 2 | 0.99 | 2 | 479 |
| 4 | 7 | 7 | 14 | 19 | 24 | 18 | 17 | 37 | 20 | 145 | 90 | 2 | 0.99 | 2 | 488 |
| 5 | 9 | 7 | 16 | 16 | 20 | 15 | 15 | 29 | 19 | 120 | 90 | 2 | 1.1 | 2 | 506 |
| 6 | 15 | 14 | 29 | 15 | 16 | 14 | 14 | 26 | 16 | 107 | 90 | 2 | 0.99 | 2 | 396 |
| 7 | 20 | 10 | 30 | 17 | 19 | 20 | 13 | 33 | 11 | 120 | 99 | 1 | 1.43 | 2 | 908 |
| 8 | 15 | 16 | 31 | 11 | 15 | 12 | 11 | 25 | 15 | 95 | 100 | 2 | 1.96 | 2 | 430 |
| 9 | 7 | 9 | 16 | 17 | 21 | 19 | 16 | 35 | 19 | 135 | 90 | 2 | 1.02 | 2 | 501 |
| 10 | 12 | 8 | 20 | 13 | 15 | 15 | 12 | 20 | 17 | 98 | 90 | 2 | 1.06 | 2 | 512 |
| 11 | 11 | 12 | 23 | 17 | 21 | 16 | 16 | 32 | 19 | 129 | 100 | 2 | 1.07 | 2 | 455 |
| 14 | 12 | 11 | 23 | 16 | 21 | 17 | 15 | 31 | 17 | 125 | 100 | 2 | 1.45 | 2 | 585 |
| 15 | 14 | 10 | 24 | 18 | 21 | 16 | 15 | 30 | 17 | 125 | 100 | 2 | 1.18 | 2 | 286 |
| 16 | 18 | 18 | 36 | 13 | 12 | 13 | 10 | 19 | 15 | 87 | 90 | 2 | 0.94 | 1 | 393 |
| 17 | 14 | 11 | 25 | 12 | 15 | 11 | 11 | 23 | 15 | 93 | 80 | 2 | 1.3 | 2 | 481 |
| 18 | 14 | 14 | 28 | 14 | 19 | 16 | 13 | 30 | 19 | 119 | 50 | 1 | 0.93 | 1 | 541 |
| 19 | 15 | 12 | 27 | 14 | 15 | 14 | 12 | 27 | 14 | 102 | 95 | 2 | 0.99 | 2 | 293 |
| 20 | 14 | 11 | 25 | 20 | 17 | 15 | 15 | 31 | 16 | 122 | 100 | 1 | 0.92 | 1 | 359 |
Outcomes after intervention (T1).
| ID | Anxiety | Depression | Negative emotion | Physical domain | Psychological domain | Independence domain | Social domain | Environment domain | Spirituality domain | Quality of life | VAS | Self-report adherence | MPR | MPR (binary) | CD4 (/µL) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 11 | 8 | 19 | 18 | 21 | 19 | 15 | 35 | 17 | 133 | 100 | 2 | 1.1 | 2 | 665 |
| 2 | 12 | 14 | 26 | 17 | 18 | 16 | 13 | 27 | 10 | 107 | 100 | 2 | 0.94 | 1 | 340 |
| 3 | 17 | 13 | 30 | 12 | 13 | 12 | 12 | 22 | 13 | 89 | 100 | 2 | 0.99 | 2 | 318 |
| 4 | 7 | 9 | 16 | 20 | 24 | 14 | 16 | 39 | 18 | 140 | 100 | 2 | 0.99 | 2 | 488 |
| 5 | 7 | 8 | 15 | 18 | 21 | 16 | 16 | 32 | 20 | 131 | 100 | 2 | 0.81 | 1 | 488 |
| 6 | 13 | 14 | 27 | 14 | 15 | 14 | 13 | 26 | 14 | 102 | 90 | 2 | 1.03 | 2 | 386 |
| 7 | 14 | 12 | 26 | 17 | 22 | 19 | 14 | 29 | 15 | 123 | 99 | 2 | 0.99 | 2 | 690 |
| 8 | 18 | 15 | 33 | 12 | 15 | 14 | 12 | 28 | 11 | 97 | 95 | 2 | 1.27 | 2 | 333 |
| 9 | 14 | 14 | 28 | 16 | 19 | 17 | 14 | 33 | 16 | 123 | 90 | 2 | 0.99 | 2 | 453 |
| 10 | 13 | 10 | 23 | 14 | 16 | 14 | 12 | 20 | 9 | 91 | 100 | 2 | 0.98 | 2 | 512 |
| 11 | 12 | 14 | 26 | 19 | 19 | 17 | 18 | 34 | 14 | 129 | 100 | 1 | 0.99 | 2 | 462 |
| 12 | 13 | 10 | 23 | 16 | 19 | 18 | 14 | 32 | 14 | 122 | 100 | 2 | 1.11 | 2 | 511 |
| 14 | 13 | 10 | 23 | 17 | 20 | 16 | 13 | 31 | 17 | 122 | 100 | 2 | 0.96 | 2 | 444 |
| 15 | 14 | 12 | 26 | 18 | 19 | 15 | 17 | 30 | 19 | 126 | 90 | 2 | 0.85 | 1 | 297 |
| 16 | 20 | 15 | 35 | 12 | 14 | 13 | 11 | 20 | 16 | 91 | 90 | 2 | 1.07 | 2 | 436 |
| 17 | 15 | 14 | 29 | 11 | 14 | 14 | 11 | 25 | 14 | 94 | 100 | 2 | 1.14 | 2 | 473 |
| 18 | 15 | 12 | 27 | 11 | 19 | 16 | 14 | 28 | 16 | 111 | 60 | 1 | 0.85 | 1 | 510 |
| 19 | 17 | 14 | 31 | 14 | 14 | 14 | 12 | 24 | 12 | 96 | 90 | 1 | 1.01 | 2 | 351 |
| 20 | 14 | 10 | 24 | 19 | 17 | 16 | 15 | 30 | 19 | 124 | 97 | 1 | 1.17 | 2 | 307 |
Content of intervention sessions.
| Session | Didactic components | Activity/Topic |
|---|---|---|
| 1 | An explanation for group goals, physiological effects of stress | Ice-breaking activity, collection of questions and expectations |
| 2 | Conception and interpretation of CBT | What dose HIV infection mean to me? |
| 3 | Definition and practice skills of mindfulness | Why am I a gay? |
| 4 | Identification of cognitive distortions and automatic thoughts | Intimate relationships |
| 5 | Rational thought replacement | How to minimize the impact of medication on life? |
| 6 | Coping skills training | What will I do when physicians reject me? |
| 7 | Assertiveness training | Career development |
| 8 | Emotion management | Fake marriage and surrogacy |
| 9 | Identification of social support | HIV confidentiality and notification |
| 10 | Summary | Look into the mirror |
| Subject | Nursing and Health Professions |
| Specific subject area | Mental Health Nursing, AIDS Care |
| Type of data | Tables |
| How data were acquired | Questionnaires include a standardized demographic questionnaire, a 4-item Patient Health Questionnaire-4 (PHQ-4) for screening participants’ depression and anxiety, a 14-item Hospital Anxiety and Depression Scale (HADS), a 31-item WHOQOL-HIV BREF, a 2-item self-report adherence questionnaire, and numerical 0–100 visual analogue scale (VAS). We asked two questions for self-reported medication adherence. ①In the past month, did you miss taking medication or mistakenly take medication? ②In the past month, did you delay or take medication ahead of time by more than 2 h? If a participant answered “no” to both questions, we defined him/her as having good adherence; otherwise, the participant belonged to modest adherence category. The questionnaire is provided as a supplementary file. |
| Every participant was receiving free antiretroviral therapy (ART) under the Chinese National Policies of “Four Frees and One Care for HIV/AIDS” | |
| Data format | Raw data |
| Parameters for data collection | The parameters included depression, anxiety, quality of life, medication adherence, CD4 lymphocyte count. |
| Description of data collection | We invited two nurses in the outpatient department to help us collect data. Neither of them participated in the intervention, so the data collection was blinded. The data collectors distributed paper questionnaires or let participants scan a QR code to fill out the questionnaire online. Data collectors checked the paper questionnaire on the spot and gave the questionnaire back if the patients had missed any questions. Online questionnaires could be submitted only after answering all the questions. Medical records were checked on the computers in the hospital to obtain patients’ follow-up intervals and CD4 lymphocyte counts. |
| Data source location | Shanghai Public Health Center Affiliated with Fudan University, Shanghai, China |
| Data accessibility | All the data for this randomized controlled trial are accessible in this data article. |